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Background: Airways of lung cancer patients are often colonized by fungi. Some of these colonizing fungi, under
particular conditions, produce cancerogenic mycotoxins. Given the recent interest in the infective origin of lung
cancer, with this preliminary study we aim to give our small contribution to this field of research by analysing the
fungal microbiome of the exhaled breath condensate of lung cancer patients from Puglia, a region of Italy.
Methods: We enrolled 43 lung cancer patients and 21 healthy subjects that underwent exhaled breath condensate
and bronchial brushing collection. The fungal incidence and nature of sample collected were analysed by using a
selected media for Aspergillus species.
Results: For the first time we were able to analyse the fungal microbioma of the exhaled breath condensate. 27.9%
of lung cancer patients showed a presence of Aspergillus niger, or A. ochraceus or Penicillium ssp. while none of the
healthy subjects did so.
Conclusion: The results confirmed the high percentage of fungal colonization of the airways of lung cancer
patients from Puglia, suggesting the need to conduct further analyses in this field in order to evaluate the exact
pathogenetic role of these fungi in lung cancer as well as to propose efficient, empirical therapy.
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Lung airways are perpetually exposed to inhaled particu-
late materials that include pollens, viruses, bacterial and
fungal spores [1]. While many of these particles are in-
nocuous, some spores have the potential to germinate
and cause invasive lung diseases [1]. A recent theory sug-
gests that infections could also trigger lung cancerogenesis
[2]. This hypothesis has been formulated mainly for viru-
ses, although it has been not excluded that also bacteria
and fungi could be involved.
If it is possible that the infections could cause lung
cancer, it is sure that the lungs of subjects with cancer
are particularly susceptible to infection that significantly
compromises the patient’s prognosis [2]. The spectrum* Correspondence: ge.carpagnano@unifg.it
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article, unless otherwise stated.of pulmonary infections depends on the underlying im-
munologic deficit or deficits, whereas fungal infections
are common if neutropenia persists [3].
Lung cancer is also characterized by airways inflam-
mation, that usually follows cigarette smoking which is
likely to play a role in cancer transformation [4,5]. The
inflammatory status also further compromises host lungs,
promoting tissue invasion and systemic dissemination of
the infection [4,5].
The main fungus that could play a role in lung cancer
transformation by colonizing the airways is the Asper-
gillus, a mold that forms conidia which, owing to their
small size, can bypass mucociliary clearance mechanisms
and are inhaled into terminal airways and phagocytosed
by alveolar macrophages (AMØs) [6-8]. Toxigenic As-
pergillus species are common in the Mediterranean en-
vironment, colonizing different crops, including maize,ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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Table 1 Anthropometric, clinical and microbiological data
from NSCLC subjects and controls
NSCLC Controls
Number 43 21
Age (Years) 68.4 ± 9.2 64.1 ± 13.1
Sex Male (%) 26 11
Smoke habit: Smokers/Ex-Smokers 25 12
Non smokers 18 9









Brushing (%) 11.6% -
EBC (%) 11.6% -
Aspergillus ochraceus Brushing (%) 6% -
EBC (%) 6% -
Pennicilium ssp Brushing (%) 9.3% -
EBC (%) 9.3% -
Abbreviations: NSCLC non small cell lung cancer, EBC exhaled breath
condensate.
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to produce mycotoxins, such as aflatoxin, ochratoxin A
and fumonisins [12], when host plants are stressed by
extreme temperature or moisture conditions, poor soil
fertility or insect damage.
Despite the potential clinical and therapeutic conse-
quences of the hypotheses of lung cancerogenesis trig-
gered by fungal infection (and particularly by Aspergillus)
and notwithstanding the prevalent rates of mold colo-
nization in lung cancer patients significantly increased in
the last decade [13], no comprehensive studies are avai-
lable on this field. The few studies present in literature
have described airways’ fungal colonization in lung cancer
patients or as a one-off report or simply express this as
the consequence of the immunodepressive status charac-
teristic of tumours [14-17]. However, several studies are
available supporting the viral origin of lung cancer [2,18].
Among these studies, one emerging from our group re-
cently analysed viral colonization in the exhaled breath
condensate (EBC) of non-small cell lung cancer (NSCLC)
patients, involving a sample from airways that is com-
pletely non-invasive and apparently suitable for microbio-
logical studies ([2], unpublished data). We support the
potential of this sample as it contains volatile, soluble and
OMIC markers, most of which have already been demon-
strated to be useful in the non-invasive diagnosis of sev-
eral lung diseases, and particularly of lung cancer, which
still results in many fatalities, mainly because it is always
diagnosed at an advanced stage, as there are no non-
invasive screening tools providing a key for its early detec-
tion and improving a person’s chances of survival.
With this study we want to give a preliminary contri-
bution to this field of research, giving a view of the inci-
dence and nature of fungal colonisations in lung cancer
patients from Puglia and correlating eventual positivity
with anthropometric, clinical and oncologic data. Thus,
for the first time to our knowledge, we analysed the fungal
microbiome in the EBC, comparing results with paired
bronchial brushing.
Methods
Characteristics of the patients
64 consecutive patients with a suspicion of lung cancer
who consented to the study were enrolled at the Unit of
Thoracic Surgery, Casa di Cura La Madonnina, Bari and
at the Department of Respiratory Disease, Foggia Uni-
versity (Table 1). Written informed consent was obtained
from all the subjects upon approval of the study by the
Ethics Committees of the University of Foggia.
All the patients were enrolled in the study before pa-
thological diagnosis. All of them also underwent standard
staging procedures consisting in a physical examination,
serum chemistry analysis, brain, chest and abdomen CT
scans, and a radionuclide bone scan.In such cases the definitive diagnosis of malignancy
derived from a positive cytohistology of the samples is
obtained broncoscopically. Following the histological
analysis carried out on specimens, 21 subjects turned
out to be negative and were considered controls. In the
remaining 43 subjects, the suspicions of lung cancer
were confirmed. Squamous cell carcinoma was diagnosed
in 36 (83.7%) subjects, whereas 7 (16.2%) subjects were
found to be affected by adenocarcinoma. Overall the
NSCLC patients 16 (37.2%) were classified as stage I, 5
(11.6%) as stage II, 12 (27.9%) as stage III and 10
(23.2%) as stage IV.
All the subjects underwent EBC and bronchial brush-
ing collection (the latter was carried out during bron-
choscopy). All subjects underwent a fungal investigation
in these samples. Type and frequency of these colonisa-
tions were analyzed.
Information on their smoking habit was acquired at
the time of diagnosis.
Twenty-five of the NSCLC patients were current/
ex-smokers (58.1%, 43.3 ± 25.2 pack/year), of whom 8
ex-smokers (32%) had quitted smoking 9.65 ± 8.5 years
previously, whereas 18 were non-smokers. A detailed
history relating to their family history of lung cancer
or any other cancer was collected in a pre-tested pro-
form.
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Bronchial brushing specimens were collected in an ice-
cold phosphate-buffered saline solution during fiberop-
tic bronchoscopy. The sample was transferred on freshly
prepared Dichloran Rose-Bengal Chloramphenicol Agar
(DRBC, Oxoid) medium. The plates were incubated at
25°C for 7 days and examined daily.
EBC collection and processing
1 mL of EBC in one setting from each patient at the time
of diagnosis.
The EBC was collected by using a condenser (Eco-
Screen Jaeger, Wurzburg, Germany). The condensate
was transferred on freshly prepared Dichloran Rose-
Bengal Chloramphenicol Agar (DRBC, Oxoid) medium.
The plates were incubated at 25°C for 7 days and exam-
ined daily.
Fungal culture and analysis
Aspergillus colonies were subcultured for subsequent
identification to species level. Species names were deter-
mined by following the taxonomic keys of Klich [18].
Culture were incubated for 7 days on CYA (Czapek
Yeast Extract Agar) at 25°C and 37°C, CZ (CzapekDox
Agar) and MEA (Malt Extract Agar) at 25°C to enable
morphological features exploited as diagnostic charac-
ters. Penicillium colonies were identified only at genus
level.
Statistical analysis
In order to assess the association between categorical
variables such as sex, smoking habit or fungi positivity
in the brushing or in the EBC and positivity to lung can-
cer or between histological subtypes or TNM stage and
mold positivity, the chi square test (or Fisher exact’s test,
when necessary) were calculated. T-student was used for
independent samples in order to assess the differences in
continuous variables (age, number of pack/years smoked)
between lung cancer patients and controls.
A p value of < 0.05 was considered statistically
significant.
Results
Lung cancer cases and healthy subjects enrolled in the
present study numbered 43 and 21, respectively. Demo-
graphic and clinical data of study subjects are summa-
rized in Table 1.
We were able to detect a fungal colonization by Asper-
gillus niger, Aspergillus ochraceus and Penicillium ssp in
the EBC.
12 (27.9%) of NSCLC patients, and 0 (0%) controls
turned out to be fungi colonized in the EBC: 5 by Asper-
gillus niger (11.6%), 3 by Aspergillus ochraceus (6%), 4 by
Penicillum spp. (9.3%).Fungi positivity in the EBC was always confirmed in
paired bronchial brushing. The EBC was found to have a
similar sensibility compared to the bronchial brushing
for fungi detection.
When analyzing lung cancer patients no difference
was found according to sex, age, histotype, stage, smok-
ing habit, pack years, time since quitting smoking in
subjects with fungal colonization (p > 0.05).
Discussion
This was a preliminary study that aimed to analyse the
incidence and nature of fungal colonization in lung can-
cer patients from Region Puglia of Italy. For the first
time to our knowledge, we tested fungal microbioma of
exhaled breath condensate and paired bronchial bru-
shing of patients with diagnosed lung cancer and of
healthy subjects and in 27.9% of lung cancer patients we
detected the presence of mold (Aspergillus niger, A.
ochraceus and Penicillium ssp), but not in any of the
healthy subjects. The fungal positivity in airways didn’t
correlate with the oncologic data.
It has been suggested that the fungal colonization
could contribute to or trigger - as do other virus infec-
tions (HPV, CMV etc) - pathophysiologic processes asso-
ciated with lung cancer [19]. However, while there is
evidence of the involvement of specific fungal species in
asthma, chronic obstructive pulmonary disease (COPD)
[20,21] and cystic fibrosis (CF) [21-24], little is known of
the airway fungal microbiota in the pathogenesis of lung
cancer [19].
Given the nascent of airway microbiome research in
lung cancer and some recent efforts to advance these
areas, this article has analysed fungal microbiota in the
EBC and bronchial aspiration of lung cancer patients
from Region Puglia of Italy [25-29]. There are only a few
studies that have investigated fungal colonization in the
airways of lung cancer patients [14] using bronchial aspi-
rates [14], bronchoalveolar lavage [30], sputum [15] or
lung tissue [17]. All these studies have described fun-
gal positivity as a one-off report or as the result of
the immunodepression.
Bearing in mind that identifying other risk factors
(more than the smoking habit) could have socio-economic
consequences for lung cancer, offering a useful tool for
prevention programs that are still in a state of bankruptcy,
we have designed this preliminary study with the aim
of analysing the possible fungal involvement in lung
cancerogenesis.
In consideration of the usefulness of using non-
invasive methods to analyse the airways of these pa-
tients feeling the brunt of several diagnostic tests and
often of surgery, we tested the fungal microbiome for
the first time in the EBC. Our group previously demon-
strated the possibility to analyse viral colonization in this
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the recent theory on a possible infective aetiology of lung
tumours. In this study we sought to direct our efforts to
the identification of the new cancerogenic microrganisms
in the EBC, toward which the screening programs could
be directed, by testing fungal microbiome.
We found a positivity for Aspergillus niger and A.
ochraceus in samples from lung cancer patients, which
are species of fungi that may release cancerogenic myco-
toxins such as ocratoxin A e fumonisins. These findings
led us to suggest that also these microorganisms and
their toxic secondary metabolites may play a role in lung
cancer development, although further studies are needed
to support this hypothesis.
Furthermore, we observed that fungal positivity in this
sample was always the same as had been observed in
paired bronchial brushing. The overlap of molds in EBC
and bronchial brushing proved that the EBC contains
identical information on airway colonisation as previously
demonstrated for HPV [2], CMV, EBV (unpublished data)
and somatic DNA alterations specific to lung cancer [31],
but also further supported the high sensibility and specifi-
city of this sample, confirming its potential usefulness in
oncological clinical practice.
We were unable to find any correlation between fungi
positivity and sex, age, histotype, stage, smoking habit of
subjects studied that would help us in the definition of
the pathogenetic role of fungi identified in lung cancer
patients. However, the number of patients enrolled in
this study was low and justified our results, which we in-
tend to verify on a larger population.
Another recognized limit of the study was not to have
tested the presence of fungi in paired plasma, something
that might help us to better interpret the origin of fungi
in the airways of patients with lung cancer and also its
significance.
Further very important analyses should be addressed
also to analyze fungal genotypes isolated, in order to
asses their ability to produce toxins, and above all, to
evaluate the effective presence in human fluids or in
lung tumor tissue of mycotoxins potentially produced by
Aspergillus species isolated.
This was just a preliminary study that will be followed
by a genomic and epigenomic characterization and my-
cotoxin analysis, which we hope will help us in defining
the association between this mold, lung cancerogenesis
and the pathogenetic mechanisms involved.
We further are planning to better study whether
the fungi colonization is the cause or consequence of
lung cancer investigating the immunologic status of
the fungi-positive patients through the analysis of the
density of infiltrating inflammatory cells in surgical
tissue samples and the dosage of the plasmatic immuno-
globin concentration.Conclusions
In conclusion, it can be stated that we have demon-
strated that the exhaled breath condensate is a suitable
sample, even for the fungal colonization of airways. Fur-
themore, we found that 28% of lung cancer patients from
Region Puglia of Italy showed Apergillus niger, Aspergillus
ochraceus and penicillium spp in their airways, opening
up future perspectives in this field.
With this study we couldn’t verify whether fungal co-
lonization is the cause or consequence of lung cancer
but we can offer a broader view on the infective status
of airways of lung cancer patients. In consideration of
the potential of our results, we support any future stud-
ies in this emerging field that could open up the possi-
bility of microbiota manipulation as a novel therapeutic
strategy for screening, treatment or management of lung
cancer.
Abbreviation
EBC: Exhaled breath condensate.
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